TY  - CONF

T1  - tAnGo: A randomized phase III trial of gemcitabine (gem) in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy (CT) for women with early-stage breast cancer (EBC)

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2008/05/20

AU  - Poole CJ

AU  - Hiller L

AU  - Howard HC

AU  - Dunn JA

AU  - Canney P

AU  - Wardley AM

AU  - Kennedy MJ

AU  - Coleman RE

AU  - Leonard RC

AU  - Earl HM

AU  - Collaborators TT

ED  - 

VL  - 26

IS  - 15

Y2  - 2025/10/10

ER  -